NanoViricides, Inc. (NASDAQ:NNVC) | WebDisclosure

Basculer en Français

10779	Companies
232605	Keywords
161117	Articles
123939	Press releases

Home
Companies
NanoViricides, Inc.

PRESS RELEASE

published on 05/20/2024 at 12:30, 2 years 2 months ago

Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Potential Cure
NanoViricides, Inc. announces strong antiviral activity of NV-387 against RSV, Influenza A, and Coronaviruses in lethal lung infection models, potentially offering a cure for RSV infection

NV-387 Clinical Trials NanoViricides Inc. Antiviral RSV
BRIEF

published on 05/15/2024 at 12:35, 2 years 2 months ago

NanoViricides Reports Financial Update and Advancements in Clinical Trials

NanoViricides NV-387 Financial Report Clinical Trials Antiviral Treatment
BRIEF

published on 05/15/2024 at 12:35, 2 years 2 months ago

NanoViricides annonce une mise à jour financière et des progrès dans les essais cliniques

NanoViricides NV-387 Rapport Financier Essais Cliniques Traitement Antiviral
PRESS RELEASE

published on 05/15/2024 at 12:30, 2 years 2 months ago

NanoViricides Has Filed its Quarterly Report
NanoViricides, Inc. reports advancing NV-387 to Phase II Clinical Trial for RSV infection treatment. Financial status and future plans discussed

NV-387 Phase II Clinical Trial NanoViricides Inc. RSV Infection Antiviral Nanomedicines
BRIEF

published on 05/14/2024 at 12:35, 2 years 2 months ago

NanoViricides Announces Breakthrough in RSV Treatment with NV-387

NanoViricides NV-387 Pharmaceutical Innovation RSV Treatment Antiviral Research
BRIEF

published on 05/14/2024 at 12:35, 2 years 2 months ago

NanoViricides annonce une percée dans le traitement du VRS avec le NV-387

NanoViricides NV-387 Innovation Pharmaceutique Traitement Contre Le VRS Recherche Antivirale
PRESS RELEASE

published on 05/14/2024 at 12:30, 2 years 2 months ago

A Novel Broad-Spectrum Antiviral with Activity Against RSV
NanoViricides, Inc. announces complete survival of animals lethally infected with RSV in lungs upon NV-387 oral treatment. Promising antiviral activity shown in study

NV-387 NanoViricides Inc. Antiviral Treatment RSV Infection Lung Infection
BRIEF

published on 05/08/2024 at 12:35, 2 years 2 months ago

NanoViricides Announces Promising Results with NV-387 in Potentially Treating Smallpox and Mpox

NanoViricides NV-387 Tecovirimat Smallpox Mpox
BRIEF

published on 05/08/2024 at 12:35, 2 years 2 months ago

NanoViricides annonce des résultats prometteurs avec le NV-387 dans le traitement potentiel de la variole et de la Mpox

NanoViricides NV-387 Tecovirimat Variole Mvariole
PRESS RELEASE

published on 05/08/2024 at 12:30, 2 years 2 months ago

A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
NanoViricides reports NV-387 shows strong orthopoxvirus activity against Smallpox/Mpox via inhalation and skin transmission. Study highlights efficacy in lethal animal models, supporting clinical development potential

NanoViricides NV-387 Clinical Development Orthopoxvirus Antiviral

Accesswire

Published on 07/30/2026 at 01:50, 1 hour 24 minutes ago

Further Assays Infill Tunkillia Pit Extension Targets
Published on 07/30/2026 at 00:50, 2 hours 24 minutes ago

Aton Announces Strategic Cooperation Relationship and Board Nominee
Published on 07/30/2026 at 00:00, 3 hours 14 minutes ago

American Hotel Income Properties REIT LP to Host Second Quarter 2026 Results Conference Call on August 6, 2026
Published on 07/29/2026 at 23:01, 4 hours 13 minutes ago

Blueberries Medical Announces C$1.1 Million Non-Brokered Private Placement
Published on 07/29/2026 at 23:00, 4 hours 14 minutes ago

NiobiumX Mining Inc. Commences Trading on the Canadian Securities Exchange Under the Symbol "NIOX", Completing Its Transition to a Niobium and Rare Earth Exploration Company Focused on Quebec's Saguenay Region

View all ACCESSWIRE

EQS Group

Published on 07/29/2026 at 21:45, 5 hours 28 minutes ago

Piramal Pharma Limited Announces Results for Q1 FY27
Published on 07/29/2026 at 21:12, 6 hours 1 minute ago

Interim individual report for the period ending on 30.06.2026
Published on 07/29/2026 at 18:25, 8 hours 48 minutes ago

International Fencing Federation prevails over Reuters in court - Court of Appeal prohibits false claims about the open letter to the IOC
Published on 07/29/2026 at 18:21, 8 hours 52 minutes ago

Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 07/29/2026 at 18:07, 9 hours 6 minutes ago

Quarterly Activities Report for the period ending 30 June 2026

Les Echos

Published on 07/29/2026 at 23:00, 4 hours 14 minutes ago

BIOPHYTIS ANNOUNCES THE AUDITING OF ITS 2025 FINANCIAL STATEMENTS AND THE RESUMPTION OF TRADING IN ITS STOCK
Published on 07/29/2026 at 23:00, 4 hours 14 minutes ago

Biophytis annonce la publication de ses comptes annuels 2025 et la reprise de la cotation de son action
Published on 07/29/2026 at 18:40, 8 hours 33 minutes ago

Aéroports de Paris SA - Mise à disposition du rapport financier semestriel 2026
Published on 07/29/2026 at 18:40, 8 hours 33 minutes ago

Aéroports de Paris SA - Availability of the 2026 financial interim report
Published on 07/29/2026 at 18:30, 8 hours 44 minutes ago

Aéroports de Paris SA - Groupe ADP 2027-2034 Economic Regulation Agreement (ERA) project

View all LES ECHOS COMFI WIRE